Berenberg Bank Analysts Give Sartorius (SRT3) a €85.00 Price Target

Berenberg Bank set a €85.00 ($101.19) price objective on Sartorius (FRA:SRT3) in a research note released on Wednesday morning. The brokerage currently has a buy rating on the stock.

A number of other equities research analysts have also weighed in on the stock. Deutsche Bank set a €80.00 ($95.24) price target on shares of Sartorius and gave the company a neutral rating in a report on Friday, December 1st. Hauck & Aufhaeuser set a €60.00 ($71.43) price objective on shares of Sartorius and gave the stock a sell rating in a report on Thursday, October 26th. set a €78.00 ($92.86) price objective on shares of Sartorius and gave the stock a neutral rating in a report on Thursday, October 26th. Nord/LB set a €70.00 ($83.33) price objective on shares of Sartorius and gave the stock a sell rating in a report on Wednesday, October 25th. Finally, Warburg Research set a €100.00 ($119.05) price objective on shares of Sartorius and gave the stock a buy rating in a report on Wednesday, October 25th. Three equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company. Sartorius currently has a consensus rating of Hold and an average price target of €77.00 ($91.67).

Shares of Sartorius (FRA SRT3) opened at €83.38 ($99.26) on Wednesday. Sartorius has a fifty-two week low of €63.72 ($75.86) and a fifty-two week high of €94.00 ($111.90).

ILLEGAL ACTIVITY WARNING: This news story was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another domain, it was stolen and republished in violation of United States and international copyright & trademark laws. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2017/12/09/berenberg-bank-analysts-give-sartorius-srt3-a-85-00-price-target.html.

About Sartorius

Sartorius Aktiengesellschaft provides laboratory and process technologies and equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry.

Analyst Recommendations for Sartorius (FRA:SRT3)

Receive News & Ratings for Sartorius AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius AG and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply